Sakar Healthcare Limited (SAKAR) - Total Liabilities
Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has total liabilities worth Rs-3.24 Billion INR (≈ $-35.09 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SAKAR long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Sakar Healthcare Limited - Total Liabilities Trend (2010–2026)
This chart illustrates how Sakar Healthcare Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Sakar Healthcare Limited.
Sakar Healthcare Limited Competitors by Total Liabilities
The table below lists competitors of Sakar Healthcare Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Palladyne AI Corp
NASDAQ:PDYN
|
USA | $23.55 Million |
|
Race Oncology Ltd
AU:RAC
|
Australia | AU$1.64 Million |
|
Propel Funeral Partners Ltd
AU:PFP
|
Australia | AU$305.83 Million |
|
Sportking India Limited
NSE:SPORTKING
|
India | Rs6.28 Billion |
|
Pt Pakuan Tbk
JK:UANG
|
Indonesia | Rp1.34 Trillion |
|
Marine Products Corporation
NYSE:MPX
|
USA | $31.14 Million |
|
Mia Teknoloji AS
IS:MIATK
|
Turkey | TL1.99 Billion |
|
Keyfield International Berhad
KLSE:5321
|
Malaysia | RM395.05 Million |
Liability Composition Analysis (2010–2026)
This chart breaks down Sakar Healthcare Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Sakar Healthcare Limited balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sakar Healthcare Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sakar Healthcare Limited (2010–2026)
The table below shows the annual total liabilities of Sakar Healthcare Limited from 2010 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs1.57 Billion ≈ $16.93 Million |
+20.63% |
| 2025-03-31 | Rs1.30 Billion ≈ $14.04 Million |
+2.74% |
| 2024-03-31 | Rs1.26 Billion ≈ $13.66 Million |
-22.49% |
| 2023-03-31 | Rs1.63 Billion ≈ $17.63 Million |
+16.17% |
| 2022-03-31 | Rs1.40 Billion ≈ $15.17 Million |
+76.83% |
| 2021-03-31 | Rs793.40 Million ≈ $8.58 Million |
+134.71% |
| 2020-03-31 | Rs338.04 Million ≈ $3.66 Million |
+25.29% |
| 2019-03-31 | Rs269.81 Million ≈ $2.92 Million |
-8.87% |
| 2018-03-31 | Rs296.07 Million ≈ $3.20 Million |
-15.61% |
| 2017-03-31 | Rs350.84 Million ≈ $3.79 Million |
+9.89% |
| 2016-03-31 | Rs319.27 Million ≈ $3.45 Million |
-9.68% |
| 2015-03-31 | Rs353.47 Million ≈ $3.82 Million |
-8.11% |
| 2014-03-31 | Rs384.65 Million ≈ $4.16 Million |
+1.29% |
| 2013-03-31 | Rs379.74 Million ≈ $4.11 Million |
+5.01% |
| 2012-03-31 | Rs361.61 Million ≈ $3.91 Million |
+1.54% |
| 2011-03-31 | Rs356.14 Million ≈ $3.85 Million |
+9.98% |
| 2010-03-31 | Rs323.82 Million ≈ $3.50 Million |
-- |
About Sakar Healthcare Limited
Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analge… Read more